← Browse by Condition
Medical Condition

gep neuroendocrine tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04893785 Phase 2
Recruiting

A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)

Enrollment
35 pts
Location
Italy
Sponsor
National Cancer Institute, Nap...
View Trial →